Cathie Wood Offloads Millions in Roku and Archer Aviation Stocks

Wednesday, Jul 16, 2025 2:10 am ET1min read

Cathie Wood's ARK Invest ETFs sold a combined $3.02 million worth of Roku (ROKU) shares, continuing a trend of reducing exposure to the stock. Meanwhile, Wood added $1.39 million worth of Caris Life Sciences (CAI) shares, signaling growing confidence in the biotechnology sector. Archer Aviation (ACHR) stock sales also increased, with Wood trimming the fund's exposure to the eVTOL aircraft maker despite growing interest in the sector.

ARK Invest ETFs, led by Cathie Wood, have made significant adjustments to their portfolios, with notable trades in Roku Inc (ROKU) and Caris Life Sciences Inc (CAI). On Monday, July 14th, 2025, ARK's ETFs sold a combined $3,022,367 worth of Roku shares, continuing a trend of reducing exposure to the stock [1]. This move follows a series of sales over the past week, signaling a potential shift in the fund's confidence in the streaming device company.

In contrast, ARK's ARKG ETF purchased 52,527 shares of Caris Life Sciences, totaling $1,392,490. This marks a new investment direction for the fund, which has not reported significant activity in Caris Life Sciences in the previous week’s trades. The purchase indicates growing confidence in the biotechnology sector, despite ongoing sell-offs in other healthcare-related stocks [1].

ARKK ETF also sold 171,557 shares of Archer Aviation Inc (ACHR), totaling $1,803,064. This follows a similar sale from the previous Friday, suggesting a consistent sell-off strategy for the aviation company [1].

These trades reflect ARK’s dynamic investment approach, as it continues to adjust its portfolios based on evolving market conditions. Investors following ARK’s ETFs should note these ongoing trends and consider the fund's strategic moves in their investment decisions.

References:
[1] https://www.investing.com/news/company-news/cathie-woods-ark-sells-roku-buys-caris-life-sciences-stock-93CH-4134564

Comments



Add a public comment...
No comments

No comments yet